Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen
Yu‐Shan Cheng, José Santinni Roma, Min Shen, et al.
Antimicrobial Agents and Chemotherapy (2021) Vol. 65, Iss. 4
Open Access | Times Cited: 25

Showing 25 citing articles:

Emerging and future strategies in the management of recalcitrant Candida auris
Nihal Bandara, Lakshman P. Samaranayake
Medical Mycology (2022) Vol. 60, Iss. 4
Open Access | Times Cited: 36
Flucytosine and its clinical usage
Liyanage Shamithra Madhumali Sigera, David W. Denning
Therapeutic Advances in Infectious Disease (2023) Vol. 10
Open Access | Times Cited: 30
Azole resistance in Candida auris: mechanisms and combinatorial therapy
Puneet Jangir, Sapna Kalra, Sunita Tanwar, et al.
Apmis (2023) Vol. 131, Iss. 8, pp. 442-462
Closed Access | Times Cited: 22
Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi
Lucie Peyclit, Hanane Yousfi, Jean‐Marc Rolain, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 488-488
Open Access | Times Cited: 41
Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health
Haroldo César de Oliveira, Bárbara Tavares Bezerra, Márcio L. Rodrigues
ACS Bio & Med Chem Au (2022) Vol. 3, Iss. 2, pp. 137-146
Open Access | Times Cited: 21
Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern
Shyam Kumar Mishra, Muhammad Yasir, Mark Willcox
The Lancet Microbe (2023) Vol. 4, Iss. 7, pp. e482-e483
Open Access | Times Cited: 14
An overview to drug repurposing
Khushal Khambhati, Abdulrahman H. Alessa, Vijai Singh
Progress in molecular biology and translational science (2024), pp. 1-8
Closed Access | Times Cited: 3
Drug repurposing against Candida auris: A systematic review
Alireza Izadi, Sanaz Aghaei Gharehbolagh, Fatemeh Sadeghi, et al.
Mycoses (2022) Vol. 65, Iss. 8, pp. 784-793
Closed Access | Times Cited: 16
Small molecules for combating multidrug-resistant superbug Candida auris infections
Jie Tu, Na Liu, Yahui Huang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 11, pp. 4056-4074
Open Access | Times Cited: 16
Discovery of a new chemical scaffold for the treatment of superbug Candida auris infections
Jie Tu, Tianbao Zhu, Qingwen Wang, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 6
The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B
Hanna Stieber, Lara Junghanns, Hannah Wilhelm, et al.
Mycoses (2024) Vol. 67, Iss. 4
Open Access | Times Cited: 1
The Potential of Dutasteride for Treating Multidrug-Resistant Candida auris Infection
J. Francis Borgio, Noor B. Almandil, P. Selvaraj, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 810-810
Open Access | Times Cited: 1
A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets
Daniel Zamith‐Miranda, Heino Heyman, Meagan Burnet, et al.
mBio (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 13
Novel avenues for identification of new antifungal drugs and current challenges
Josef Jampílek
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 9, pp. 949-968
Closed Access | Times Cited: 8
Broad susceptibility of Candida auris strains to 8-hydroxyquinolines and mechanisms of resistance
Matthew B. Lohse, Matthew T. Laurie, Sophia Levan, et al.
mBio (2023)
Open Access | Times Cited: 4
Initial Results of the International Efforts in Screening New Agents against Candida auris
Vanice Rodrigues Poester, Lívia Silveira Munhoz, Jéssica Louise Benelli, et al.
Journal of Fungi (2022) Vol. 8, Iss. 8, pp. 771-771
Open Access | Times Cited: 4
Mechanistic insights into antifungal potential of Alexidine dihydrochloride and hexachlorophene in Candida albicans: a drug repurposing approach
Ayesha Ansari, Darshan Kumar, Payal Gupta, et al.
Archives of Microbiology (2024) Vol. 206, Iss. 9
Open Access
Reshaping the Therapeutic Landscape: Drug Repurposing for Emerging Infectious Diseases and Rare Diseases
Amritha G. Nambiar, Anuj A. Biswas, Ashish Kumar Agrawal, et al.
Drug repurposing (2024), pp. 135-171
Closed Access
A novel diterpenic derivative produced by Streptomyces chrestomyceticus ADP4 is a potent inhibitor of biofilm and virulence factors in Candida albicans and C. auris
Radha Singh, Jyoti Shukla, Mohd Sajid Ali, et al.
Journal of Applied Microbiology (2024) Vol. 135, Iss. 6
Closed Access
Repurposing a human acetyl-CoA carboxylase inhibitor firsocostat to treat fungal candidiasis alone and in combination
Tianyu Chen, Jing Yao, Keao Quan, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 68, Iss. 1
Open Access | Times Cited: 1
Prospective Medicines against the Widespread, Emergent, and Multidrugresistant Opportunistic Fungal Pathogen Candida auris: A Breath of Hope
Lívia S. Ramos, Laura Nunes Silva, Thaís P. Mello, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 16, pp. 1297-1305
Closed Access | Times Cited: 2
AHistoplasma capsulatumlipid metabolic map identifies antifungal targets
Daniel Zamith‐Miranda, Heino Heyman, Meagan Burnet, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 1
Agrochemical Lessons for Infectious Disease Research: New Resistance Breaking Antifungal Hits against Candida auris
Christian Winter, Isabella Siepe, Andrew K. Wise, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 2, pp. 136-140
Closed Access
Broad sensitivity ofCandida aurisstrains to quinolones and mechanisms of resistance
Matthew B. Lohse, Matthew T. Laurie, Sophia Levan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
The sphingolipid inhibitor myriocin increases susceptibility of Candida auris to amphotericin B
Hanna Stieber, Lara Junghanns, Hannah Wilhelm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top